Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Michael S Wertheim"'
Autor:
Alexander Spira, Michael S Wertheim, Edward J Kim, Benjamin Tan, Heinz-Josef Lenz, Petros Nikolinakos, Patricia L Rich, Genevieve Jehl, Andreas Machl, Rena Ito, James L Gulley, Scott Kopetz
Publikováno v:
The oncologist, vol 28, iss 2
Colorectal cancer (CRC) is a heterogeneous and complex disease with limited treatment options. Targeting transforming growth factor β (TGF-β) and programmed death ligand 1 pathways may enhance antitumor efficacy. Bintrafusp alfa is a first-in-class
Autor:
Fitzroy Dawkins, Andres Forero-Torres, William Jeffery Edenfield, Justin Call, Li Zhou, Daniel O. Persky, Paolo Caimi, Xuejun Chen, Swaminathan P. Iyer, Carolina Escobar, Abdulraheem Yacoub, Michael S. Wertheim, Douglas J DeMarini, Radhakrishnan Ramchandren, Martin Gutierrez, Luke P. Akard, Tycel Phillips
This phase 1/2 study assessed parsaclisib (INCB050465), a next-generation, potent, and highly selective phosphatidylinositol 3-kinase δ (PI3Kδ) inhibitor, in patients with relapsed or refractory B-cell malignancies, alone or in combination with a J
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcecfa88ad0f4c321ee1122db18dc82d
https://europepmc.org/articles/PMC6543513/
https://europepmc.org/articles/PMC6543513/
Autor:
Jiping Zha, Rodryg Ramlau, J. Goldschmidt, David R. Spigel, Maciej Krzakowski, Benoit Godbert, Gilles Robinet, Michael S. Wertheim, George R. Blumenschein, Thomas Ervin, Robert L. Yauch, Premal Patel, Fabrice Barlesi, Ramaswamy Govindan, Wei Yu, Sergey Orlov, Amy C. Peterson, Taral Patel, See Chun Phan, Davey B. Daniel
Publikováno v:
Journal of Clinical Oncology. 31:4105-4114
Purpose Increased hepatocyte growth factor/MET signaling is associated with poor prognosis and acquired resistance to epidermal growth factor receptor (EGFR) –targeted drugs in patients with non–small-cell lung cancer (NSCLC). We investigated whe
Autor:
Paula W. Annunziato, Donald M. Poretz, Michael R. Mullane, Jon E. Stek, Michael S. Wertheim, Tina M. Sterling, Yanli Zhao, Steven A. Pergam, Drew J. Winston, Susan B. Manoff, Luis H. Camacho, Kathleen M. Mullane, Robert F. Betts
Publikováno v:
The Journal of Infectious Diseases. 208:1375-1385
BACKGROUND Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) were assessed in immunocompromised adults. METHODS In a randomized, double-blind, placebo-controlled, multicenter study, 4 doses ZVHT or placebo were administered approximatel
Autor:
Thomas A. Hensing, Raymond Thertulien, Ravi Salgia, Frank A. Scappaticci, David R. Gandara, Rajendra S. Pradhan, Dawn M. Carlson, Nasser H. Hanna, Jiang Qian, Glenwood D. Goss, James Chih-Hsin Yang, Benjamin Besse, Ross A. Soo, Christa Lee, J. L. Ricker, Michael S. Wertheim, Eng Huat Tan, Neeraj Gupta, Julien Mazieres, Qin Qin
Publikováno v:
Journal of Thoracic Oncology. 6(8):1418-1425
Introduction This study assessed activity and safety of linifanib (ABT-869), a selective inhibitor of vascular endothelial growth factor and platelet-derived growth factor receptors, in patients with locally advanced or metastatic non-small cell lung
Autor:
Stanislav Spelda, Andrew Coates, Barry L. Dowell, Andrew Krivoshik, Jane Qian, Peter Ansell, Xiangdong Zhou, Gary S. Gordon, Rajendra S. Pradhan, Ann M. Mauer, Martin Šmakal, Evelyn McKeegan, Rosalyn A. Juergens, Charles M. Rudin, Michael S. Wertheim
Publikováno v:
Journal of Clinical Oncology. 29:1075-1082
Purpose ABT-751 is an antimitotic and vascular disrupting agent with potent preclinical anticancer activity. We conducted a phase I and randomized double-blind phase II study of pemetrexed with ABT-751 or placebo in patients with recurrent advanced o
Autor:
Thomas E. Jackson, Michael S. Wertheim, Paul G. D. Spry, John M Sparrow, Adam H. Ross, Jeremy P. Diamond
Publikováno v:
European Journal of Ophthalmology. 21:400-403
Purpose TO compare the diurnal intraocular pressure (IOP) profile pre and post trabeculectomy with a control group of medically controlled patients. We compared the change in mean, peak, and diurnal IOP fluctuation. Methods This was an observational
Autor:
Michael S. Wertheim, Petros Nikolinakos, Isabelle Dussault, Benjamin R. Tan, Edward J. Kim, Christoph Helwig, Patricia Rich, Heinz-Josef Lenz, Scott Kopetz, James L. Gulley, David Smith, Alexander I. Spira, Laureen S. Ojalvo
Publikováno v:
Journal of Clinical Oncology. 36:764-764
764 Background: Inhibiting the transforming growth factor β (TGF-β) pathway, which plays a key role in tumor immunosuppression, may enhance the response to programmed death 1/programmed death ligand 1 (PD-1/PD-L1) monoclonal antibodies (mAbs). M782
Autor:
Jean P. O'Malley, William D. Mathers, Michael S. Wertheim, F. Mackensen, Angela S. Watkins, Lyndell L Lim, James T. Rosenbaum
Publikováno v:
Ocular Immunology and Inflammation. 14:203-206
To explore the use of in-vivo confocal microscopy (IVCM) as a potential non-invasive adjunctive tool for diagnosing sarcoidosis.Conjunctivae were imaged using confocal microscopy in 10 patients with sarcoidosis and 27 control subjects. We utilized th
Autor:
Théa Faivre, Tycel Phillips, Andres Forero-Torres, William Jeffery Edenfield, Michael S. Wertheim, Harry Miao, Jennifer Pulini, Matt Spear, Swamy Yeleswaram, Rod Ramchandren, Li Zhou, Martin Gutierrez, Maureen Bleam
Publikováno v:
Cancer Research. 76:CT056-CT056
Background: PI3Kδ inhibitors have demonstrated efficacy in the treatment of B-cell malignancies, but off-target toxicity and/or the inability to achieve near-complete inhibition of the PI3Kδ pathway may affect the depth and duration of response. IN